v3 Template
E

EurekaBio

Biotechnology / Cell and Gene Therapy (CGT) ~240 employees
Founded
--
Employees (Est.)
~240
12 leaders known
Total Funding
$40.0M
Funding Rounds
1
Last Funding
2024-03-07

About EurekaBio

EurekaBio is a biotechnology company focused on advancing cell and gene therapy (CGT) by providing innovative solutions for viral vector production and cell therapy manufacturing. Their mission is to reduce costs, increase efficiency, and support the commercialization of CGT through pioneering research and automated platforms.

Products & Services

EuLV™ System:A system for viral vector R&D and scale-up solutions, designed to produce high-titer and high-quality lentiviral vectors for cell and gene therapy.
EuLV ONE™ Lentiviral Packaging System:A lentiviral packaging system for viral vector production, supporting R&D and scale-up in the CGT industry.
CellSep™ PRO:A solution for cell therapy manufacturing, aimed at automating and enhancing the preparation and production of cell therapy products.
CellSep™ MAX:An advanced solution for cell therapy manufacturing, focusing on cost reduction and efficiency in CGT product preparation.
EuBioX System:An interdisciplinary biotechnology R&D platform integrating automation and biotechnology for biological research and development projects.

Specialties

Viral Vector R&D and Scale-up Cell Therapy Manufacturing Lentiviral Vector Production Automated Biotechnology Platforms

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B+
T: -
FT: Series B+
A: 40000000
MR: -
FA: $40 Million
FAN: 40000000
D: 2024-03-07
FD: 2024-03-07
3 investors
Series B+ Latest
2024-03-07
$40.0M
3 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

I

Iris

Buyer

G

Gary

Marketing Specialist

A

Alina

Janitor

S

Simon

Researcher

A

Abelard

Consultant

J

Julia

Customer

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

EurekaBio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Cell and Gene Therapy (CGT)
Company Size
~240 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro